NCT06606990 2026-05-13Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid CancersNational Cancer Institute (NCI)Phase 1 Recruiting40 enrolled
NCT02719977 2023-08-04A Phase I Study of CX5461Canadian Cancer Trials GroupPhase 1 Completed41 enrolled